Skip to main content
Top
Published in: Reactions Weekly 1/2016

01-07-2016 | Case report

Bortezomib/carfilzomib

Thrombotic microangiopathy: 11 case reports

Published in: Reactions Weekly | Issue 1/2016

Login to get access

Excerpt

Author Information
An event is serious (FDA MedWatch definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * requires intervention to prevent permanent impairment or damage
Footnotes
1
Patients' details were added from "Table I" of the article.
 
Metadata
Title
Bortezomib/carfilzomib
Thrombotic microangiopathy: 11 case reports
Publication date
01-07-2016
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2016
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-016-19793-1

Other articles of this Issue 1/2016

Reactions Weekly 1/2016 Go to the issue

Case report

Regorafenib

Case report

Regorafenib

Case report

Risperidone

Case report

Cotrimoxazole